British Pharmacopoeia 2026 Single-user online licence

Product Description

A single-user licence grants access to one designated user and offers a flexible solution – ideal for individuals or smaller organisations. A licence provides access from 1 August 2025 to 31 March 2027 (a total of 20 months).

The BP 2026 edition supersedes the BP 2025 and becomes legally effective on 1 January 2026 with all European Pharmacopoeia texts included. Updated annually, the British Pharmacopoeia (BP) is the only comprehensive collection of authoritative official standards for UK pharmaceutical substances and medicinal products.
It includes approximately 4,000 monographs, which are legally enforced by the Human Medicines Regulations 2012. Medicinal products or active pharmaceutical ingredients sold or supplied in the UK must comply with the relevant monograph. All monographs and requirements of the European Pharmacopoeia (Ph. Eur.) are reproduced in the BP, making the BP a convenient and fully comprehensive set of standards that can be used across Europe and internationally.

Optional add-ons include:
• BP Archive (from BP 2014 onwards): £200 per licence
• British Approved Names (BAN): £150 per licence

New for the BP 2026 edition

• 19 new BP monographs and 34 new monographs reproduced from the 11th edition of the Ph. Eur., as amended by issues 11.6 to 11.8
• Two new appendices, four supplementary chapters, and six new infrared reference spectra have been added to the collection
• 12 new BPCRS have been produced and referenced
• 131 amended BP monographs
• All monographs from the Ph. Eur. 11th edition and Ph. Eur. issues up to 11.8
• The Ph. Eur. 12th edition, comprising issues 12.1, 12.2 and 12.3, included as an in-year online update

Can take up to 24 hours to process